These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 34460968)

  • 1. Propensity score-based analysis of 30-day survival in cardiogenic shock patients supported with different microaxial left ventricular assist devices.
    Nersesian G; Potapov EV; Nelki V; Stein J; Starck C; Falk V; Schoenrath F; Krackhardt F; Tschöpe C; Spillmann F
    J Card Surg; 2021 Nov; 36(11):4141-4152. PubMed ID: 34460968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impella CP use in patients with non-ischaemic cardiogenic shock.
    Maniuc O; Salinger T; Anders F; Müntze J; Liu D; Hu K; Ertl G; Frantz S; Nordbeck P
    ESC Heart Fail; 2019 Aug; 6(4):863-866. PubMed ID: 31095902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impella versus extracorporal life support in cardiogenic shock: a propensity score adjusted analysis.
    Wernly B; Karami M; Engström AE; Windecker S; Hunziker L; Lüscher TF; Henriques JP; Ferrari MW; Binnebößel S; Masyuk M; Niederseer D; Abel P; Fuernau G; Franz M; Kelm M; Busch MC; Felix SB; Thiele H; Lauten A; Jung C
    ESC Heart Fail; 2021 Apr; 8(2):953-961. PubMed ID: 33560591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry.
    Lauten A; Engström AE; Jung C; Empen K; Erne P; Cook S; Windecker S; Bergmann MW; Klingenberg R; Lüscher TF; Haude M; Rulands D; Butter C; Ullman B; Hellgren L; Modena MG; Pedrazzini G; Henriques JP; Figulla HR; Ferrari M
    Circ Heart Fail; 2013 Jan; 6(1):23-30. PubMed ID: 23212552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term mechanical circulatory support with the Impella 5.0 device for cardiogenic shock at La Pitié-Salpêtrière.
    Mastroianni C; Bouabdallaoui N; Leprince P; Lebreton G
    Eur Heart J Acute Cardiovasc Care; 2017 Feb; 6(1):87-92. PubMed ID: 26873912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the axillary Impella 5.0 device on patients with acute cardiogenic shock.
    Tarabichi S; Ikegami H; Russo MJ; Lee LY; Lemaire A
    J Cardiothorac Surg; 2020 Aug; 15(1):218. PubMed ID: 32795321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock.
    Dhruva SS; Ross JS; Mortazavi BJ; Hurley NC; Krumholz HM; Curtis JP; Berkowitz A; Masoudi FA; Messenger JC; Parzynski CS; Ngufor C; Girotra S; Amin AP; Shah ND; Desai NR
    JAMA; 2020 Feb; 323(8):734-745. PubMed ID: 32040163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impella Microaxial Flow Catheter Is Safe and Effective for Treatment of Myocarditis Complicated by Cardiogenic Shock: An Analysis From the Global cVAD Registry.
    Annamalai SK; Esposito ML; Jorde L; Schreiber T; A Hall S; O'Neill WW; Kapur NK
    J Card Fail; 2018 Oct; 24(10):706-710. PubMed ID: 30244180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of survival of patients in cardiogenic shock treated by surgically implanted Impella 5+ short-term left ventricular assist device.
    Nersesian G; Tschöpe C; Spillmann F; Gromann T; Roehrich L; Mueller M; Mulzer J; Starck C; Falk V; Schoenrath F; Potapov E
    Interact Cardiovasc Thorac Surg; 2020 Oct; 31(4):475-482. PubMed ID: 32879947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Indications of IMPELLA Short-Term Mechanical Circulatory Support in a Tertiary Centre.
    Monteagudo Vela M; Simon A; Riesgo Gil F; Rosenberg A; Dalby M; Kabir T; García Saez D; Panoulas V
    Cardiovasc Revasc Med; 2020 May; 21(5):629-637. PubMed ID: 31859100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impella 5.0 Support in INTERMACS II Cardiogenic Shock Patients Using Right and Left Axillary Artery Access.
    Schibilsky D; Lausberg H; Haller C; Lenglinger M; Woernle B; Haeberle H; Rosenberger P; Walker T; Schlensak C
    Artif Organs; 2015 Aug; 39(8):660-3. PubMed ID: 26147682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock.
    Gaudard P; Mourad M; Eliet J; Zeroual N; Culas G; Rouvière P; Albat B; Colson P
    Crit Care; 2015 Oct; 19():363. PubMed ID: 26453047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of Impella implantation and outcomes in cardiogenic shock or high-risk percutaneous coronary revascularization.
    Tarantini G; Masiero G; Burzotta F; Pazzanese V; Briguori C; Trani C; Piva T; De Marco F; Di Biasi M; Pagnotta P; Mojoli M; Casu G; Giustino G; Lorenzoni G; Montorfano M; Ancona MB; Pappalardo F; Chieffo A;
    Catheter Cardiovasc Interv; 2021 Aug; 98(2):E222-E234. PubMed ID: 33793051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Outcomes of Impella Microaxial Devices Used to Salvage Cardiogenic Shock as a Bridge to Durable Circulatory Support or Cardiac Transplantation.
    Cheng R; Tank R; Ramzy D; Azarbal B; Chung J; Esmailian F; Kobashigawa JA; Moriguchi JD; Arabia FA
    ASAIO J; 2019; 65(7):642-648. PubMed ID: 30281541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-centre experience with the Impella CP, 5.0 and RP in 109 consecutive patients with profound cardiogenic shock.
    Jensen PB; Kann SH; Veien KT; Møller-Helgestad OK; Dahl JS; Rud CS; Jensen MK; Jensen LO; Schmidt H; Møller JE
    Eur Heart J Acute Cardiovasc Care; 2018 Feb; 7(1):53-61. PubMed ID: 29148290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of mechanical circulatory support with venoarterial extracorporeal membrane oxygenation or Impella for patients with cardiogenic shock: a propensity-matched analysis.
    Karatolios K; Chatzis G; Markus B; Luesebrink U; Ahrens H; Divchev D; Syntila S; Jerrentrup A; Schieffer B
    Clin Res Cardiol; 2021 Sep; 110(9):1404-1411. PubMed ID: 33185749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant implantation of Impella
    Pappalardo F; Schulte C; Pieri M; Schrage B; Contri R; Soeffker G; Greco T; Lembo R; Müllerleile K; Colombo A; Sydow K; De Bonis M; Wagner F; Reichenspurner H; Blankenberg S; Zangrillo A; Westermann D
    Eur J Heart Fail; 2017 Mar; 19(3):404-412. PubMed ID: 27709750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality in patients with cardiogenic shock treated with the Impella CP microaxial pump for isolated left ventricular failure.
    Sieweke JT; Berliner D; Tongers J; Napp LC; Flierl U; Zauner F; Bauersachs J; Schäfer A
    Eur Heart J Acute Cardiovasc Care; 2020 Mar; 9(2):138-148. PubMed ID: 29405734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary trends in use of mechanical circulatory support in patients with acute MI and cardiogenic shock.
    Helgestad OKL; Josiassen J; Hassager C; Jensen LO; Holmvang L; Udesen NLJ; Schmidt H; Berg Ravn H; Moller JE
    Open Heart; 2020; 7(1):e001214. PubMed ID: 32201591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impella support compared to medical treatment for post-cardiac arrest shock after out of hospital cardiac arrest.
    Karatolios K; Chatzis G; Markus B; Luesebrink U; Ahrens H; Dersch W; Betz S; Ploeger B; Boesl E; O'Neill W; Kill C; Schieffer B
    Resuscitation; 2018 May; 126():104-110. PubMed ID: 29522829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.